Determinants of growth differentiation factor 15 plasma levels in outpatients with peripheral arterial disease
Background: Growth differentiation factor 15 (GDF-15) is a robust prognostic biomarker in patients with cardiovascular (CV) disease, and a better understanding of its clinical determinants is desirable. We aimed to study the associations between GDF-15 levels and traditional CV risk factors, indicat...
Saved in:
Main Authors: | Emma Skau, Philippe Wagner, Jerzy Leppert, Johan Ärnlöv, Pär Hedberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Upsala Medical Society
2024-12-01
|
Series: | Upsala Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ujms.net/index.php/ujms/article/view/11001/18551 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot–Marie Tooth patients
by: Dace Pretkalnina, et al.
Published: (2025-01-01) -
Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study
by: Ali Boustani, et al.
Published: (2025-01-01) -
GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models
by: Yu Huang, et al.
Published: (2024-12-01) -
The value of growth differentiation factor 15 as a biomarker for peripheral artery disease in diabetes patients
by: Wan-Chi Chuang, et al.
Published: (2025-01-01) -
Identification of Inflammatory Biomarkers for Predicting Peripheral Arterial Disease Prognosis in Patients with Diabetes
by: Kian Draper, et al.
Published: (2024-12-01)